Revvity Common Stock Net 2010-2024 | RVTY

Revvity common stock net from 2010 to 2024. Common stock net can be defined as the value of common equity ownership.
  • Revvity common stock net for the quarter ending September 30, 2024 was $0.122B, a 1.02% decline year-over-year.
  • Revvity common stock net for 2023 was $0.123B, a 2.28% decline from 2022.
  • Revvity common stock net for 2022 was $0.126B, a 0.05% increase from 2021.
  • Revvity common stock net for 2021 was $0.126B, a 12.62% increase from 2020.
Revvity Annual Common Stock Net
(Millions of US $)
2023 $123
2022 $126
2021 $126
2020 $112
2019 $111
2018 $111
2017 $110
2016 $110
2015 $112
2014 $112
2013 $113
2012 $115
2011 $113
2010 $116
2009 $117
Revvity Quarterly Common Stock Net
(Millions of US $)
2024-09-30 $122
2024-06-30 $123
2024-03-31 $123
2023-12-31 $123
2023-09-30 $123
2023-06-30 $124
2023-03-31 $126
2022-12-31 $126
2022-09-30 $126
2022-06-30 $126
2022-03-31 $126
2021-12-31 $126
2021-09-30 $126
2021-06-30 $112
2021-03-31 $112
2020-12-31 $112
2020-09-30 $112
2020-06-30 $112
2020-03-31 $111
2019-12-31 $111
2019-09-30 $111
2019-06-30 $111
2019-03-31 $111
2018-12-31 $111
2018-09-30 $111
2018-06-30 $111
2018-03-31 $111
2017-12-31 $110
2017-09-30 $110
2017-06-30 $110
2017-03-31 $110
2016-12-31 $110
2016-09-30 $110
2016-06-30 $109
2016-03-31 $109
2015-12-31 $112
2015-09-30 $112
2015-06-30 $113
2015-03-31 $113
2014-12-31 $112
2014-09-30 $113
2014-06-30 $113
2014-03-31 $113
2013-12-31 $113
2013-09-30 $112
2013-06-30 $112
2013-03-31 $112
2012-12-31 $115
2012-09-30 $115
2012-06-30 $114
2012-03-31 $114
2011-12-31 $113
2011-09-30 $113
2011-06-30 $113
2011-03-31 $113
2010-12-31 $116
2010-09-30 $118
2010-06-30 $118
2010-03-31 $118
2009-12-31 $117
2009-09-30 $117
2009-06-30 $117
2009-03-31 $116
Sector Industry Market Cap Revenue
Medical Medical Services $13.376B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00